YMRC
CBPO

Yorktown Management & Research Company’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Yorktown Management & Research Company’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,000
Closed -$320K – 367
2018
Q3 		$320K Hold
4,000
– – 0.09% 257
2018
Q2 		$397K Hold
4,000
– – 0.12% 183
2018
Q1 		$324K Buy
+4,000
New +$323K 0.1% 235

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Yorktown Management & Research Company's CBPO Position: Q4 2018 in Review

Yorktown Management & Research Company sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2018, closing a stake of 4,000 shares — an estimated $320K sold.

Yorktown Management & Research Company first reported a position in CBPO in Q1 2018 and held it in 3 quarters. The position peaked at $397K in Q2 2018. 67 funds tracked by Wall St. Rank hold CBPO as of Q4 2018.

  • Yorktown Management & Research Company reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2018 after selling out during the quarter.
  • Yorktown Management & Research Company sold 4,000 China Biologic Products Holdings, Inc. shares in Q4 2018, an estimated $320K.
  • Yorktown Management & Research Company first reported a position in China Biologic Products Holdings, Inc. in Q1 2018 and held it in 3 quarters.
  • Yorktown Management & Research Company's China Biologic Products Holdings, Inc. position peaked at $397K in Q2 2018.
  • 67 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2018.

Based on Yorktown Management & Research Company's 13F filing for Q4 2018, filed 8 Feb 2019.